@incollection{, 9390B7265A0155294F7D0095CF9BAA30 , author={{Patricia Karen PaucarLescano}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}1931929 } @incollection{b0, , title={{The need of dermatologists, psychiatrists and psychologists joint care in psychodermatology}} , author={{ RDoglia }} , journal={{An Bras Dermatol}} 92 1 , year={2017} } @incollection{b1, , title={{Relación bidireccional de las patologías cutáneas con los trastornos mentales}} , author={{ KPaucar }} , journal={{Rev Cient Cienc Méd}} 21 1 , year={2018} } @incollection{b2, , title={{Pyschodermatology: a trip through history}} , author={{ KFranca } and { AChacon } and { JLedon } and { JSavas } and { KNouri }} , journal={{An Bras Dermatol}} 88 5 , year={2013} } @book{b3, , author={{ SYadav } and { TNarang } and { MKumaran }} , title={{Psychodermatology: A comprehensive review}} } @incollection{b4, , title={{}} , journal={{Indian J Dermatol, Venereol Leprol}} 79 , year={2013} } @incollection{b5, , title={{Brain on stress: How the social environment gets under the skin}} , author={{ BMcewen }} , journal={{Proc Natl Acad Sci U S A}} 109 , year={2012} } @incollection{b6, , title={{Neuroimmunology of Stress: Skin Takes Center Stage}} , author={{ P CArck } and { ASlominski } and { T CTheoharides } and { E MPeters } and { RPaus }} , journal={{J Invest Dermatol}} 126 , year={2006} } @incollection{b7, , title={{Brain-skin connection: stress, inflammation and Skin Aging}} , author={{ YChen } and { JLyga }} , journal={{Inflamm Allergy Drug Targets}} 13 , year={2014} } @incollection{b8, , title={{Tratamiento con psicofármacos de los trastornos psicodermatológicos}} , author={{ JEscalas } and { AGuerra } and { MRodríguez-Cerdeira }} , journal={{Actas Dermatosifiliogr}} 101 , year={2010} } @incollection{b9, , title={{The integrative role of the sigh in psychology, physiology, pathology and neurobiology}} , author={{ JRamirez }} , journal={{Prog Brain Res}} 209 , year={2014} } @incollection{b10, , title={{Hopelessness, depression and alexithymia in Young Turkish soldiers suffering from alopecia areata}} , author={{ KSayar } and { OKöse } and { SEbrinc } and { MSetin }} , journal={{Dermatol Psychosom}} 2 , year={2001} } @incollection{b11, , title={{Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20}} , author={{ H LRichards } and { D GFortune } and { C EGriffiths } and { CJMain }} , journal={{J Psychosom Res}} 58 , year={2005} } @incollection{b12, , title={{The presence of alexithymia investigated by the TAS-20 in chronic urticaria patients: A preliminary report}} , author={{ GManiaci } and { M SEpifanio } and { M AMarino } and { SAmoroso }} , journal={{Allerg Immunol}} 38 , year={2006} } @incollection{b13, , title={{Stressfull life events, social support, attachment security and alexithymia in vitíligo. A case-control study}} , author={{ APicardi } and { PPasquini } and { M SCattaruzza } and { PGaetano } and { C FMelchi } and { GBaliva }} , journal={{Psychother Psychosom}} 72 , year={2003} } @incollection{b14, , title={{Neurophysiological, cognitive-behavioral and neurochemical effects in practitioners of transcendental meditation -A literature review}} , author={{ A CMosini } and { MSaad } and { CCasaletti } and { DeMedeiros } and { RPrieto } and { M F } and { CameloFrederico }} , journal={{Rev Assoc Med Bras}} 65 5 , year={2019} } @incollection{b15, , title={{Psychiatric Evaluation of the Dermatology Patient}} , author={{ M AGupta } and { A KGupta } and { C NEllis } and { CSKoblenzer }} , journal={{Dermatol Clin}} 23 , year={2005} } @incollection{b16, , title={{A metaanalysis of the effectiveness of psychological interventions for adults with skin conditions}} , author={{ A CLavda } and { T LWebb } and { ARThompson }} , journal={{Br J Dermatol}} 167 , year={2012} } @incollection{b17, , title={{Psychological interventions in the management of common skin diseases}} , author={{ PShenefelt }} , journal={{Psychol Res Behav Manag}} 3 , year={2010} } @incollection{b18, , title={{Nonpharmacological Management of Psychodermatologic Conditions}} , author={{ RFried }} , journal={{Semin Cutan Med Surg}} 32 2 , year={2013} } @incollection{b19, , title={{Hypnosis in dermatology}} , author={{ PShenefelt }} , journal={{Arch Dermatol}} 136 , year={2000} } @incollection{b20, , title={{Diagnosis and treatment of trichotillomania}} , author={{ LSchreiber } and { B LOdlaug } and { JEGrant }} , journal={{Neuropsychiatry}} 2 , year={2011} } @incollection{b21, , title={{Burn injuries benefit from massage therapy}} , author={{ TField } and { MPeck } and { SKrugman } and { TTuchel } and { SSchanberg } and { CKuhn }} , journal={{J Burn Care Rehabil}} 19 , year={1998} } @incollection{b22, , title={{Current Psychosomatic Practice}} , author={{ G AFava } and { FCosci } and { NSonino }} , journal={{Psychother Psychosom}} 86 , year={2017} } @incollection{b23, , title={{Does it matter who provides psychological interventions for medically unexplained symptoms? A meta-analysis}} , author={{ HGerger } and { MHlavica } and { JGaab } and { TMunder } and { JBarth }} , journal={{Psychother Psychosom}} 84 , year={2015} } @incollection{b24, , title={{Short-term psychodynamic psychotherapy for somatic disorders}} , author={{ AAbbass } and { SKisely } and { KKroenke }} , journal={{Psychother Psychosom}} 78 , year={2009} } @incollection{b25, , title={{Effects of interventions involving the family in the treatment of adult patients with chronic physical disease}} , author={{ MHartmannn } and { EBazner } and { BWild } and { IEisler } and { WHerzog }} , journal={{Psychother Psychosom}} 79 , year={2010} } @incollection{b26, , title={{The clinical inadequacy of evidence-based medicine and the need for a conceptual framework based on clinical judgment}} , author={{ G AFava } and { JGuidi } and { CRafanelli } and { NSonino }} , journal={{Psychother Psychosom}} 84 , year={2015} } @incollection{b27, , title={{Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines}} , author={{ CConnor }} , journal={{Clinical, Cosmetic and Investigational Dermatology}} 10 , year={2017} } @incollection{b28, , title={{The efficacy and safety of clonazepam in patients with anxiety disorder taking newer antidepressants: a multicenter naturalistic study}} , author={{ S MWang } and { J BKim } and { J KSakong }} , journal={{Clin Psychopharmacol Neurosci}} 14 2 , year={2016} } @incollection{b29, , title={{Generalized anxiety disorder: practical assessment and management}} , author={{ M GKavan } and { GElsasser } and { EJBarone }} , journal={{Am Fam Phys}} 79 9 , year={2009} } @incollection{b30, , title={{A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder}} , author={{ R JBielski } and { ABose } and { CCChang }} , journal={{Ann Clin Psychiatry}} 17 2 , year={2005} } @incollection{b31, , title={{Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study}} , author={{ J RDavidson } and { ABose } and { AKorotzer } and { HZheng }} , journal={{Depress Anxiety}} 19 4 , year={2004} } @incollection{b32, , title={{Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder}} , author={{ J RDavidson } and { ABose } and { QWang }} , journal={{J Clin Psychiatry}} 66 11 , year={2005} } @incollection{b33, , title={{Doxepin plasma concentrations: is there really a therapeutic range?}} , author={{ SLeucht } and { WSteimer } and { SKreuz } and { DAbraham } and { P JOrsulak } and { WKissling }} , journal={{J Clin Psychopharmacol}} 21 4 , year={2001} } @incollection{b34, , title={{Psychomotor depressive symptoms may differentially respond to venlafaxine}} , author={{ A BSingh } and { C ABousman } and { C HNg } and { ByronKBerk } and { M }} , journal={{Int Clin Psychopharmacol}} 28 3 , year={2013} } @incollection{b35, , title={{Effects of different antidepressant treatments on the core of depression}} , author={{ T CBaghai } and { DEser } and { HJMoller }} , journal={{Dialogues Clin Neurosci}} 10 3 , year={2008} } @incollection{b36, , title={{Comparative efficacy and acceptability of 12 newgeneration antidepressants: a multipletreatments meta-analysis}} , author={{ ACipriani } and { T AFurukawa } and { GSalanti }} , journal={{Lancet}} 373 9665 , year={2009} } @incollection{b37, , title={{Delusions of parasitosis}} , author={{ E CLevin } and { UGieler }} , journal={{Semin Cutan Med Surg}} 32 2 , year={2013} } @incollection{b38, , title={{Delusions of parasitosis; suggested dialogue between dermatologist and patient}} , author={{ VPatel } and { JYKoo }} , journal={{J Dermatolog Treat}} 26 5 , year={2015} } @incollection{b39, , title={{Psychodermatology: the mind and skin connection}} , author={{ JKoo } and { ALebwohl }} , journal={{Am Fam Phys}} 64 11 , year={2001} } @incollection{b40, , title={{Three cases of delusional parasitosis caused by dopamine agonists}} , author={{ SFlann } and { JShotbolt } and { BKessel }} , journal={{Clin Exp Dermatol}} 35 7 , year={2010} } @incollection{b41, , title={{Delusional infestation induced by piribedil add-on in Parkinson's disease}} , author={{ MKolle } and { PLepping } and { JKassubek } and { CSchonfeldt-Lecuona } and { RWFreudenmann }} , journal={{Pharmacopsychiatry}} 43 6 , year={2010} } @incollection{b42, , title={{Delusional infestation may be caused by recreational drug usage in some patients, but they may not disclose their habit}} , author={{ C LMarshall } and { VWilliams } and { CEllis } and { R ETaylor } and { ABewley }} , journal={{Clin Exp Dermatol}} 42 1 , year={2017} } @incollection{b43, , title={{Pimozide in dermatologic practice: a comprehensive review}} , author={{ C RLorenzo } and { KooJ }} , journal={{Am J Clin Dermatol}} 5 5 , year={2004} } @incollection{b44, , title={{Second-generation antipsychotics in primary and secondary delusional parasitosis: outcome and efficacy}} , author={{ R WFreudenmann } and { PLepping }} , journal={{J Clin Psychopharmacol}} 28 5 , year={2008} } @incollection{b45, , title={{Delusional infestation: treatment outcome with antipsychotics in consecutive patients (using standardized reporting criteria)}} , author={{ MHuber } and { PLepping } and { RPycha } and { MKarner } and { JSchwitzer } and { RWFreudenmann }} , journal={{Gen Hosp Psychiatry}} 33 6 , year={2011} } @incollection{b46, , title={{Aripiprazole in the treatment of delusional parasitosis with ocular and dermatologic presentations}} , author={{ W LHuang } and { LRChang }} , journal={{J Clin Psychopharmacol}} 33 2 , year={2013} } @incollection{b47, , title={{Aripiprazole as a viable alternative for treating delusions of parasitosis}} , author={{ BLadizinski } and { K LBusse } and { TBhutani } and { JYKoo }} , journal={{J Drugs Dermatol}} 9 12 , year={2010} } @incollection{b48, , title={{Almost all antipsychotics result in weight gain: a meta-analysis}} , author={{ MBak } and { AFransen } and { JJanssen } and { JVan Os } and { MDrukker }} , journal={{PLoS One}} 9 4 e94112 , year={2014} } @incollection{b49, , title={{A randomized, double-blind, placebo-controlled pilot study of betahistine to counteract olanzapine-associated weight gain}} , author={{ NBarak } and { YBeck } and { JHAlbeck }} , journal={{J Clin Psychopharmacol}} 36 3 , year={2016} } @incollection{b50, , title={{Betahistine decreases olanzapine induced weight gain and somnolence in humans}} , author={{ NBarak } and { YBeck } and { JHAlbeck }} , journal={{J Psychopharmacol}} 30 3 , year={2016} } @incollection{b51, , title={{Ameliorating antipsychotic-induced weight gain by betahistine: mechanisms and clinical implications}} , author={{ JLian } and { X FHuang } and { NPai } and { CDeng }} , journal={{Pharmacol Res}} 106 , year={2016} } @incollection{b52, , title={{Patients with delusional infestation (delusional parasitosis) often require prolonged treatment as recurrence of symptoms after cessation of treatment is common: an observational study}} , author={{ SWong } and { ABewley }} , journal={{Br J Dermatol}} 165 4 , year={2011} } @incollection{b53, , title={{Managing obsessive compulsive disorder}} , author={{ VBrakoulias }} , journal={{Aust Prescr}} 38 4 , year={2015} } @incollection{b54, , title={{Cognitive behavioral and pharmacological treatments of OCD in children: a systematic review and meta-analysis}} , author={{ L GOst } and { E NRiise } and { G JWergeland } and { BHansen } and { GKvale }} , journal={{J Anxiety Disord}} 43 , year={2016} } @incollection{b55, , title={{Remote cognitive-behavior therapy for obsessivecompulsive symptoms: a metaanalysis}} , author={{ BWootton }} , journal={{Clin Psychol Rev}} 43 , year={2016} } @incollection{b56, , title={{N-acetylcysteine in trichotillomania: further thoughts}} , author={{ JGoulding }} , journal={{Br J Dermatol}} 172 6 , year={2015} } @incollection{b57, , title={{N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebocontrolled study}} , author={{ J EGrant } and { B LOdlaug } and { SKim }} , journal={{Arch Gen Psychiatry}} 66 7 , year={2009} } @incollection{b58, , title={{N-Acetylcysteine in the treatment of trichotillomania: remarkable results in two patients}} , author={{ DOzcan } and { DSeckin }} , journal={{J Eur Acad Dermatol Venereol}} 30 9 , year={2016} } @incollection{b59, , title={{N-acetylcysteine in trichotillomania: a panacea for compulsive skin disorders?}} , author={{ MTaylor } and { KBhagwandas }} , journal={{Br J Dermatol}} 171 5 , year={2014} } @incollection{b60, , title={{Pharmacotherapy for trichotillomania}} , author={{ RRothbart } and { TAmos } and { NSiegfried }} , journal={{Cochrane Database Syst Rev}} 11 7662 , year={2013} } @incollection{b61, , title={{Inexpensive solution for habit-tic deformity}} , author={{ DRing }} , journal={{Arch Dermatol}} 146 11 , year={2010} } @incollection{b62, , title={{Allergic contact dermatitis to 2-octyl cyanoacrylate}} , author={{ CBowen } and { JBidinger } and { CHivnor } and { AHoover } and { JHenning }} , journal={{Cutis}} 94 4 , year={2014} } @incollection{b63, , title={{Severe allergic contact dermatitis to dermabond prineo, a topical skin adhesive of 2-octyl cyanoacrylate increasingly used in surgeries to close wounds}} , author={{ M DDavis } and { MJStuart }} , journal={{Dermatitis}} 27 2 , year={2016} } @incollection{b64, , title={{Allergic contact dermatitis caused by Dermabond ((R))}} , author={{ SLefevre } and { AValois } and { FTruchetet }} , journal={{Contact Dermatitis}} 75 4 , year={2016} } @book{b65, , title={{}} , author={{ C SLee } and { RAccordino }} } @incollection{b66, , title={{Psycopharmacology in dermatology}} , author={{ JHoward } and { JKoo }} , journal={{Dermatologic Therapy}} 21 , year={2008} }